Retinal Vascular Disease Symposium

Related

• 

  Rates of Post Intravitreal Anti-VEGF Injection Endophthalmitis: Management Strategies and Visual Acuity Outcomes From the AAO IRIS Registry

  Alia K Durrani, MD

  Annual Meeting Talks

  2023

• 

  Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv

  Raj K. Maturi, MD

  Updates from the Field

  2017

• 

  Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

  Emmanuel Chang, MD PhD FACS FASRS

  Annual Meeting Talks

  2023